Show simple item record

dc.contributor.authorBunting, D
dc.date.accessioned2019-06-05T12:59:05Z
dc.date.available2019-06-05T12:59:05Z
dc.date.issued2018-10
dc.identifier.citationDiabet Med. 2018 Oct;35(10):1371-1374. doi: 10.1111/dme.13679. Epub 2018 Jun 2.en
dc.identifier.urihttp://hdl.handle.net/20.500.12904/1641
dc.descriptionAuthor(s) Pre Print. 12 Month Embargo on Post-Print. No PDFen
dc.description.abstractAIMS: To undertake a prospective point prevalence study of the prevalence of active Charcot neuro-inflammatory osteoarthropathy (Charcot disease) in a circumscribed part of England and to audit the time elapsing between disease onset and first diagnosis. METHODS: The prevalence of active Charcot disease of the foot during a single month was assessed by specialist foot care teams at seven secondary care services in the East Midlands region of England. RESULTS: A total of 90 cases were identified, representing 4.3 per 10 000 of the 205 033 total diabetes population of the region. The time elapsed from first presentation to any healthcare professional until diagnosis was also assessed. While the diagnosis was suspected or confirmed in one-third of patients within 2 weeks, it was not made for 2 months or more in 23 patients (24%). CONCLUSIONS: Non-specialist professionals should have greater awareness of the existence of this uncommon complication of diabetes in the hope that earlier diagnosis will lead to lesser degrees of deformity.en
dc.language.isoenen
dc.subjectCharcot Diseaseen
dc.subjectCharcot Neur-Inflammatory Osteoarthropathyen
dc.titlePrevalence of active Charcot disease in the East Midlands of Englanden
dc.typeArticleen


This item appears in the following Collection(s)

Show simple item record